← board
IDXX
distress 1/10 · well-funded / low risk$542.780%today-29% from 52w high
Revenue
$1141M
Liquidity
$201M
Runway
—
Shares 1y
-1%
Price & events
-21.5% over 6M
CatalystRating changeDilutionFinancingdashed = today
-0.4%
1D
-5.8%
1W
+0.3%
1M
-3.2%
3M
-21.8%
6M
+0.4%
1Y
+15.4%
2Y
-21.8%
5Y
+10.4%
All
Overview
- Market Cap
- $42.82B
- Enterprise Value
- $42.92B
- Volume
- 11.76K
- 52 Week Range
- $515 – $767
- Total Shares
- 78.88M
- Float Shares
- 78.58M
- Short %
- 2.81%
- % Held by Insiders
- 0.22%
- % Held by Institutions
- 96.12%
- RVOL
- 0.02x
- Beta
- 1.55
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 1
- 2026-08-04Confirmed 100%earningsEarningsEarnings releaseyahoo
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
buy · target $708 (+31% upside) · 14 analysts
- 2026-04-28UBSNeutral
- 2026-04-15CitigroupNeutral
- 2026-03-31StifelBuy
- 2026-02-09Piper SandlerNeutral
- 2026-02-05BarclaysOverweight
- 2026-02-03BTIGBuy
Competitors
- none identified
Recent news
- 2026-07-17IDEXX Laboratories (IDXX) Could Be 19% Undervalued After Stifel Flags Better Pet Health Trends - simplywall.st
- 2026-07-17IDEXX Laboratories (IDXX) Could Be 19% Undervalued After Stifel Flags Better Pet Health Trends - simplywall.st
- 2026-07-17IDEXX Laboratories (IDXX) Could Be 19% Undervalued After Stifel Flags Better Pet Health Trends - Sahm
- 2026-07-16Avoiding Lag: Real-Time Signals in (IDXX) Movement - Stock Traders Daily
- 2026-07-15Idexx Laboratories (IDXX) Shows Promising Growth Potential - GuruFocus
- 2026-07-14Is IDEXX Laboratories Inc (IDXX) a Bargain After 4.2% Drop? GF V - GuruFocus
- 2026-07-14Is IDEXX Laboratories Inc (IDXX) a Bargain After 4.2% Drop? GF Value Says Undervalued - GuruFocus
- 2026-07-14Why IDEXX Laboratories (IDXX) Stock Is Down Today - Quiver Quantitative
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.